Related Experiment Videos
[Visceral artery aneurysms]
H Lauschke1, J Rudolph, J Textor
1Klinik und Poliklinik für Allgemein, Viszeral, Thorax und Gefässchirurgie, Rheinische Friedrich,Wilhelms Universität Bonn, Germany.
Zentralblatt Fur Chirurgie
|July 3, 2002
Summary
Visceral artery aneurysms (VAA) are rare but dangerous, often presenting with rupture. Early diagnosis and individualized treatment, surgical or interventional, are crucial for managing these uncommon vascular lesions.
Area of Science:
- Vascular Surgery
- Gastroenterology
- Abdominal Imaging
Context:
- Visceral artery aneurysms (VAA) are uncommon vascular lesions with a reported autopsy frequency of 0.1-0.2%.
- Rupture remains a common initial presentation (22%), associated with significant mortality (8.5%) despite emergency interventions.
- Thromboembolic complications and rupture underscore the critical need for awareness of VAA as a differential diagnosis for abdominal pain.
Purpose:
- To review the etiology, clinical presentation, and treatment strategies for visceral artery aneurysms (VAA).
- To present a case series of 9 patients with VAA, detailing the types and locations of aneurysms observed.
- To discuss the available therapeutic options, including surgical and interventional approaches.
Summary:
- The study reviewed 9 patients with VAA, including aneurysms of the splenic artery (3), gastric artery (3), gastroepiploic artery (1), pancreaticoduodenal artery (1), and superior mesenteric artery (1).
- Surgical therapy was performed in 8 of 9 patients, while only 2 patients (22%) received interventional treatment.
- One patient died due to postoperative hemorrhage, highlighting potential complications associated with VAA treatment.
Impact:
- Emphasizes the importance of considering VAA in the differential diagnosis of abdominal pain due to potentially catastrophic outcomes.
- Highlights that both surgical and radiological interventions are viable treatment options for VAA.
- Stresses the necessity of an individualized approach for selecting the optimal therapeutic strategy for each patient with VAA.